By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Britannia Pharmaceuticals Limited 

41-51 Brighton Road
Redhill
Surrey    RH1 6YS  England
Phone: 44-0-1737-773741 Fax: 44-0-1737-762672


SEARCH JOBS


Industry
Pharmaceutical

Segment
Pharmaceuticals





Company News
Ipsen Sells the North American1 Development and Marketing Rights for Apokyn® to Britannia Pharmaceuticals Limited, Achieving a Key Milestone in the Execution of its New North American Strategy 11/3/2011 6:20:55 AM
Ipsen Sells the North American1 Development and Marketing Rights for Apokyn® to Britannia Pharmaceuticals Limited, Achieving a Key Milestone in the Execution of its New North American strategy 11/2/2011 12:05:01 PM
Kyowa Hakko Kogyo Co., Ltd. To Introduce Self-Injectable Drug For Treating Parkinson's Disease From Britannia Pharmaceuticals Limited 2/23/2006 1:23:00 PM
Britannia Pharmaceuticals Limited Simplifies Apomorphine Delivery With New Pre-Filled Syringe10/19/2005 5:12:12 PM
airPharma Signs Agreement With Britannia Pharmaceuticals Limited To Bring Novel Asthma Treatment To Market10/19/2005 5:12:07 PM
Britannia Pharmaceuticals Limited Expands Nasal Powder Program With New Production Capability10/19/2005 5:11:31 PM
Bertek Pharmaceuticals, Subsidiary Of Mylan Laboratories Inc. (MYL) , Receives FDA Approval For Parkinson’s Disease Treatment (Previously Announced)10/19/2005 5:11:17 PM
Otsuka Pharmaceuticals UK Ltd Selects Britannia Pharmaceuticals Limited To Distribute Adacolumn In The United Kingdom; Novel Treatment For Inflammatory Related Diseases Provides A Significant Alternative To Other Pharmaceutical Therapies10/19/2005 5:10:55 PM
Britannia Pharmaceuticals Limited Signs Agreement With US WorldMeds, LLC To Bring First Non-Opiate Drug Addiction Treatment To The U.S.10/19/2005 5:10:48 PM
Britannia Pharmaceuticals Limited Closes 2003 With Several New Partnership Agreements And Significant Clinical Progress10/19/2005 5:09:45 PM
//-->